ArticleJournal of cancer research and clinical oncology2024

Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?

Dandan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.